Updates GLP drugs pricing and access highlight new subscription models, FDA approvals, and tighter regulatory oversight in 2024.
The FDA has approved Eli Lilly's oral GLP-1, Foundayo. Let the heated rivalry with oral Wegovy begin
Eli Lilly announced this morning that the FDA has, as was expected, approved its oral GLP-1, orforglipron, as treatment for obesity and that it will market the pill as Foundayo. The pill version of ...
Are you thinking about starting a GLP-1 medication? About 1 in 8 US adults have used GLP-1s to manage diabetes, treat heart ...
By most measures, the new GLP-1 pills are underwhelming. Earlier this month, the pharmaceutical giant Eli Lilly debuted a ...
Uncrowned is a new destination for all things MMA, boxing, wrestling, and more, featuring Ariel Helwani. Yahoo Racing is powered by Motorsport Network, providing expert reporting, analysis, and ...
A weekly injection is no longer the only way to reap the obesity management and weight loss benefits of glucagon-like peptide-1 (GLP-1) medications. The U.S. Food and Drug Administration (FDA) has ...
Drugmakers Novo Nordisk and Eli Lilly and Company have transformed the landscape of chronic weight loss management with the ...
GLP-1 drugs are fueling a surge in direct-to-consumer medications. But convenience may be replacing coordination—and creating ...
The European Medicines Agency (EMA) has approved an update to the product information for Wegovy ® injection that allows the ...
The GLP-1 market is growing fast. Here’s how much the most popular medications will cost you.
You can now choose between GLP-1 pills or shots for weight loss. Here's what you need to know to decide which one is best for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results